BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23805223)

  • 1. PUMA Cooperates with p21 to Regulate Mammary Epithelial Morphogenesis and Epithelial-To-Mesenchymal Transition.
    Zhang Y; Yan W; Jung YS; Chen X
    PLoS One; 2013; 8(6):e66464. PubMed ID: 23805223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transition.
    Zhang Y; Young A; Zhang J; Chen X
    Oncotarget; 2015 Jun; 6(16):13994-4004. PubMed ID: 26101856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition.
    Zhang Y; Yan W; Jung YS; Chen X
    J Biol Chem; 2012 May; 287(21):17746-17753. PubMed ID: 22457351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG.
    Thakur VS; Ruhul Amin AR; Paul RK; Gupta K; Hastak K; Agarwal MK; Jackson MW; Wald DN; Mukhtar H; Agarwal ML
    Cancer Lett; 2010 Oct; 296(2):225-32. PubMed ID: 20444544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic genetic dissection of p14ARF-mediated mitochondrial cell death signaling reveals a key role for p21CDKN1 and the BH3-only protein Puma/bbc3.
    Hemmati PG; Müer A; Gillissen B; Overkamp T; Milojkovic A; Wendt J; Dörken B; Daniel PT
    J Mol Med (Berl); 2010 Jun; 88(6):609-22. PubMed ID: 20419447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM; Bhattacharya S; Johnson LR
    Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21.
    Leibowitz BJ; Qiu W; Liu H; Cheng T; Zhang L; Yu J
    Mol Cancer Res; 2011 May; 9(5):616-25. PubMed ID: 21450905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress.
    Lehman JA; Waning DL; Batuello CN; Cipriano R; Kadakia MP; Mayo LD
    J Biol Chem; 2011 Oct; 286(42):36631-40. PubMed ID: 21873427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both p53-PUMA/NOXA-Bax-mitochondrion and p53-p21cip1 pathways are involved in the CDglyTK-mediated tumor cell suppression.
    Yu Z; Wang H; Zhang L; Tang A; Zhai Q; Wen J; Yao L; Li P
    Biochem Biophys Res Commun; 2009 Sep; 386(4):607-11. PubMed ID: 19540190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
    Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
    Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation.
    Jabbour AM; Daunt CP; Green BD; Vogel S; Gordon L; Lee RS; Silke N; Pearson RB; Vandenberg CJ; Kelly PN; Nutt SL; Strasser A; Borner C; Ekert PG
    Blood; 2010 Jan; 115(2):344-52. PubMed ID: 19965665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation.
    Andrysik Z; Kim J; Tan AC; Espinosa JM
    Cell Rep; 2013 May; 3(5):1346-54. PubMed ID: 23684607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction.
    Sperka T; Song Z; Morita Y; Nalapareddy K; Guachalla LM; Lechel A; Begus-Nahrmann Y; Burkhalter MD; Mach M; Schlaudraff F; Liss B; Ju Z; Speicher MR; Rudolph KL
    Nat Cell Biol; 2011 Dec; 14(1):73-9. PubMed ID: 22138576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-nutrient starvation induces cell death mediated by Bax and Puma that is counteracted by p21 and unmasked by Bcl-x(L) inhibition.
    Braun F; Bertin-Ciftci J; Gallouet AS; Millour J; Juin P
    PLoS One; 2011; 6(8):e23577. PubMed ID: 21887277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest.
    Woo TG; Yoon MH; Hong SD; Choi J; Ha NC; Sun H; Park BJ
    Oncotarget; 2017 Apr; 8(14):23690-23701. PubMed ID: 28423593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
    Lau LM; Nugent JK; Zhao X; Irwin MS
    Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.
    Schumm K; Rocha S; Caamano J; Perkins ND
    EMBO J; 2006 Oct; 25(20):4820-32. PubMed ID: 16990795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.